bepridil has been researched along with Wolff-Parkinson-White Syndrome in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Touboul, P | 1 |
| Atallah, G | 1 |
| Kirkorian, G | 1 |
| Lavaud, P | 1 |
| Kieny, JR | 1 |
| Mathieu, MP | 1 |
| Dellinger, A | 1 |
1 other study available for bepridil and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Electrophysiological action of bepridil on atrioventricular accessory pathways.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Bepridil; Female; Heart Conduction System; Humans; Male; | 1987 |